31 results on '"Engel, W.K."'
Search Results
2. G.P.4.14 In ALS, viral-dysmetabolic mechanisms acting via neuronal-nurturing cells (NNCs) could portend replacement therapy and should be sought by multi-tissue screening for rev-transcriptase (RT) and viral tracks
3. G.P.17.06 Late-onset rod myopathy with monoclonal immunoglobulin can be treatable with IVIG
4. G.P.17.07 Fever-responsive dysschwannian neuropathy (FRDN): Interferon-alpha 2a (Iα) treatment has produced remarkable recovery from total quadriplegia, the benefit now persisting 4years beyond the 14years of therapy
5. G.O.2 In sporadic inclusion-body myositis (s-IBM) muscle fibers, Parkinson-disease-associated DJ-1 is oxidized and might play a novel pathogenic role
6. G.P.13.15 In sporadic inclusion-body myositis muscle-fiber (s-IBM) cytoplasm, cytochrome C aggregates with α-synuclein and amyloid-β precursor protein (AβPP), but does not activate caspase-3
7. G.P.3.16 In skeletal muscle of patients with type-II fiber atrophy, myostatin (MSTN) and myostatin precursor protein (MSTN-PP) are both increased
8. T.P.2 01 Longer-term (>3 months) IVIG treatment to optimize clinical benefit and cellular protection usually requires an individualized adjustable schedule – not fixed regimentation
9. Tropomodulin Is Highly Concentrated at the Postsynaptic Domain of Human and Rat Neuromuscular Junctions
10. The multiple ADP/ATP translocase genes are differentially expressed during human muscle development.
11. Glucocorticoid increases acetylcholinesterase and organization of the postsynaptic membrane in innervated cultured human muscle
12. Effects of experimental spinal cord transection on substance P receptors: A quantitative autoradiography study
13. Frameshift and novel mutations in FUSin familial amyotrophic lateral sclerosis and ALS/dementia(e–Pub ahead of print)
14. CYTOLOGICAL LOCALIZATION OF CHOLINESTERASE IN DEVELOPING CHICK EMBRYO SKELETAL MUSCLE.
15. G.P.17.07 Fever-responsive dysschwannian neuropathy (FRDN): Interferon-alpha 2a (Iα) treatment has produced remarkable recovery from total quadriplegia, the benefit now persisting 4 years beyond the 14 years of therapy
16. Adult-Onset Acid Maltase Deficiency - Morphologic and Biochemical Abnormalities Reproduced in Cultured Muscle
17. G.P.2 02 In cultured human muscle fibers (CHMFs) amyloid-β precursor protein (AβPP) and proteasome inhibition increase αB-crystallin (αBC). Relevance to sporadic inclusion-body myositis (s-IBM)
18. G.P.2 01 Alpha-synuclein and parkin are novel proteins accumulated in ragged red fibers
19. G.O.6 “Pseudo-Lupus”, benign neutropenia, and other probably non-worrisome blood-component changes due to IVIG treatment
20. Cerebrospinal fluid norepinephrine and free γ-aminobutyric acid in amyotrophic lateral sclerosis
21. THE MANY CAUSES OF "IDIOPATHIC " SCOLIOSIS
22. SCANNING FOR SOFT-TISSUE AMYLOID
23. Analogs of thyrotropin-releasing hormone: Hypotheses relating receptor binding to net excitation of spinal lower motor neurons
24. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: Possible clinical implications
25. ABNORMAL IMMUNOGLOBULIN BANDS IN CEREBROSPINAL FLUID IN MYASTHENIA GRAVIS
26. Kinetic analysis of thyrotropin-releasing hormone binding in the central nervous system: evidence for receptor desensitization
27. CYTOLOGICAL LOCALIZATION OF CHOLINESTERASE IN DEVELOPING CHICK EMBRYO SKELETAL MUSCLE
28. Ultrastructural and histochemical correlations of experimental muscle regeneration
29. ALTERNATE-DAY PREDNISONE IN A PATIENT WITH MYASTHENIA GRAVIS
30. MODIFICATION BY L-DOPA OF A CASE OF PROGRESSIVE SUPRANUCLEAR PALSY
31. Cells of neural crest origin as possible models to investigate thyrotropin releasing hormone action in the central nervous system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.